{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:18:58Z","timestamp":1761862738109},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,2,18]],"date-time":"2008-02-18T00:00:00Z","timestamp":1203292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00415-008-0768-z","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T16:02:23Z","timestamp":1203004943000},"page":"649-654","source":"Crossref","is-referenced-by-count":24,"title":["Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke"],"prefix":"10.1007","volume":"255","author":[{"given":"A.","family":"Ma\u00e1sz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kisfali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Szolnoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hadarits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Melegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,18]]},"reference":[{"key":"768_CR1","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.ATV.11.4.966","volume":"11","author":"Bonithon-Kopp","year":"1991","unstructured":"Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L (1991) Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb 11:966\u2013972","journal-title":"Arterioscler Thromb"},{"key":"768_CR2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.ATV.16.2.310","volume":"16","author":"Bonithon-Kopp","year":"1996","unstructured":"Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D, et al. (1996) Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 16:310\u2013316","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"768_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2796.1999.0442f.x","volume":"245","author":"Bots","year":"1999","unstructured":"Bots ML, Hoes AW, Hofman A, Witteman JC, Grobbee DE (1999) Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med 245:269\u2013276","journal-title":"J Intern Med"},{"key":"768_CR4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.STR.0000103141.82869.77","volume":"35","author":"Elias","year":"2004","unstructured":"Elias MF, Sullivan LM, D\u2019Agostino RB, Elias PK, Beiser A, Au R, et al. (2004) Framingham stroke risk profile and lowered cognitive performance. Stroke 35:404\u2013409","journal-title":"Stroke"},{"key":"768_CR5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1194\/jlr.M500446-JLR200","volume":"47","author":"Elosua","year":"2006","unstructured":"Elosua R, Ordovas JM, Cupples LA, Lai CQ, Demissie S, Fox CS, et al. (2006) Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res 47:990\u2013996","journal-title":"J Lipid Res"},{"key":"768_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00109-003-0465-4","volume":"81","author":"Evans","year":"2003","unstructured":"Evans D, Buchwald A, Beil FU (2003) The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 81:645\u2013654","journal-title":"J Mol Med"},{"key":"768_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(03)00266-7","volume":"2","author":"Feigin","year":"2003","unstructured":"Feigin VL, Lawes CM, Bennett DA, Anderson CS (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43\u201353","journal-title":"Lancet Neurol"},{"key":"768_CR8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.ATV.0000163841.85333.83","volume":"25","author":"Genoux","year":"2005","unstructured":"Genoux A, Dehondt H, Helleboid- Chapman A, Duhem C, Hum DW, Martin G, et al. (2005) Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha. Arterioscler Thromb Vasc Biol 25:1186\u20131192","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"768_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00539-1","volume":"157","author":"Groenendijk","year":"2001","unstructured":"Groenendijk M, Cantor RM, De Bruin TW, Dallinga-Thie GM (2001) The apoAI-CIII-AIV gene cluster. Atherosclerosis 157:1\u201311","journal-title":"Atherosclerosis"},{"key":"768_CR10","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/brain\/123.9.1784","volume":"123","author":"Hassan","year":"2000","unstructured":"Hassan A, Markus HS (2000) Genetics and ischaemic stroke. Brain 123(Pt 9):1784\u20131812","journal-title":"Brain"},{"key":"768_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/JMN:29:2:177","volume":"29","author":"Havasi","year":"2006","unstructured":"Havasi V, Szolnoki Z, Talian G, Bene J, Komlosi K, Maasz A, et al. (2006) Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 29:177\u2013183","journal-title":"J Mol Neurosci"},{"key":"768_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0009-9163.2004.00199.x","volume":"65","author":"Hubacek","year":"2004","unstructured":"Hubacek JA, Skodova Z, Adamkova V, Lanska V, Poledne R (2004) The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65:126\u2013130","journal-title":"Clin Genet"},{"key":"768_CR13","doi-asserted-by":"crossref","first-page":"45462","DOI":"10.1074\/jbc.M404744200","volume":"279","author":"Jakel","year":"2004","unstructured":"Jakel H, Nowak M, Moitrot E, Dehondt H, Hum DW, Pennacchio LA, et al. (2004) The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J Biol Chem 279:45462\u201345469","journal-title":"J Biol Chem"},{"key":"768_CR14","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1194\/jlr.M400192-JLR200","volume":"45","author":"Lai","year":"2004","unstructured":"Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, Parnell LD, et al. (2004) Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45:2096\u20132105","journal-title":"J Lipid Res"},{"key":"768_CR15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/jnnp.2006.106831","volume":"78","author":"Lipska","year":"2007","unstructured":"Lipska K, Sylaja PN, Sarma SP, Kutty VR, Thankappan KR, Vasan RS, et al. (2007) Risk factors for acute ischaemic stroke in young adults in South India. J Neurol Neurosurg Psychiatry 78:959\u2013963","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"768_CR16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.metabol.2004.11.009","volume":"54","author":"Liu","year":"2005","unstructured":"Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, et al. (2005) Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54:568\u2013572","journal-title":"Metabolism"},{"key":"768_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0925-4439(03)00033-4","volume":"1637","author":"Martin","year":"2003","unstructured":"Martin S, Nicaud V, Humphries SE, Talmud PJ (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637:217\u2013225","journal-title":"Biochim Biophys Acta"},{"key":"768_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2006.04.009","volume":"191","author":"Martinelli","year":"2006","unstructured":"Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, et al. (2006) The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis 191:409\u2013417","journal-title":"Atherosclerosis"},{"key":"768_CR19","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","volume":"280","author":"Merkel","year":"2005","unstructured":"Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, et al. (2005) Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280:21553\u201321560","journal-title":"J Biol Chem"},{"key":"768_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","volume":"340","author":"O'Leary","year":"1999","unstructured":"O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14\u201322","journal-title":"N Engl J Med"},{"key":"768_CR21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.ATV.0000054194.78240.45","volume":"23","author":"Pennacchio","year":"2003","unstructured":"Pennacchio LA, Rubin EM (2003) Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 23:529\u2013534","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"768_CR22","doi-asserted-by":"crossref","first-page":"25468","DOI":"10.1074\/jbc.M301302200","volume":"278","author":"Prieur","year":"2003","unstructured":"Prieur X, Coste H, Rodriguez JC (2003) The human apolipoprotein AV gene is regulated by peroxisome proliferatoractivated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J Biol Chem 278:25468\u201325480","journal-title":"J Biol Chem"},{"key":"768_CR23","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1194\/jlr.M500040-JLR200","volume":"46","author":"Ruiz-Narvaez","year":"2005","unstructured":"Ruiz-Narvaez EA, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H (2005) APOC3\/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 46:2605\u20132613","journal-title":"J Lipid Res"},{"key":"768_CR24","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","volume":"279","author":"Schaap","year":"2004","unstructured":"Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, et al. (2004) ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279:27941\u201327947","journal-title":"J Biol Chem"},{"key":"768_CR25","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1373\/clinchem.2004.037689","volume":"50","author":"Schaefer","year":"2004","unstructured":"Schaefer JR, Sattler AM, Hackler B, Kurt B, Hackler R, Maisch B, et al. (2004) Hyperlipidemia in patients with apolipoprotein E 2\/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem 50:2214","journal-title":"Clin Chem"},{"key":"768_CR26","first-page":"1191","volume":"115","author":"Shephard","year":"1976","unstructured":"Shephard DA (1976) The 1975 Declaration of Helsinki and consent. Can Med Assoc J 115:1191\u20131192","journal-title":"Can Med Assoc J"},{"key":"768_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2003.12.003","volume":"173","author":"Szalai","year":"2004","unstructured":"Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A, et al. (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173:109\u2013114","journal-title":"Atherosclerosis"},{"key":"768_CR28","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","volume":"11","author":"Talmud","year":"2002","unstructured":"Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, et al. (2002) Relative contribution of variation within the APOC3\/A4\/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11:3039\u20133046","journal-title":"Hum Mol Genet"},{"key":"768_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1194\/jlr.M300458-JLR200","volume":"45","author":"Talmud","year":"2004","unstructured":"Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, et al. (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45:750\u2013756","journal-title":"J Lipid Res"},{"key":"768_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbadis.2006.10.012","volume":"1772","author":"van der Vleuten","year":"2007","unstructured":"van der Vleuten GM, Isaacs A, Zeng WW, Ter Avest E, Talmud PJ, Dallinga-Thie GM, et al. (2007) Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. Biochim Biophys Acta 1772:81\u201388","journal-title":"Biochim Biophys Acta"},{"key":"768_CR31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-2275(20)32016-2","volume":"41","author":"Waterworth","year":"2000","unstructured":"Waterworth DM, Hubacek JA, Pitha J, Kovar J, Poledne R, Humphries SE, et al. (2000) Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCIAPOE cluster. J Lipid Res 41:1103\u20131109","journal-title":"J Lipid Res"},{"key":"768_CR32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2005.06.043","volume":"185","author":"Wright","year":"2006","unstructured":"Wright WT, Young IS, Nicholls DP, Patterson C, Lyttle K, Graham CA (2006) SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5\/ A4\/C3\/A1 locus on chromosome 11q23 in the Northern Irish population. Atherosclerosis 185:353\u2013360","journal-title":"Atherosclerosis"},{"key":"768_CR33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2006.05.035","volume":"191","author":"Yamada","year":"2006","unstructured":"Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, et al. (2006) Prediction of genetic risk for metabolic syndrome. Atherosclerosis 191:298\u2013304","journal-title":"Atherosclerosis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-0768-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0768-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T07:58:50Z","timestamp":1630742330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-0768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,18]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-0768-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,18]]}}}